Table 1 Comparison of participants’ demographic characteristics groups wise and overall

130

90

45

45

62

27(33.30%)

35(43.20%)

Age, M (SD)

90

36.93(6.87)

37.62(6.77)

−.48

.64

Gender

Female n(%)

50

23(51.20%)

27(60.10%)

.72

.40

Male n(%)

40

22(48.90%)

18(40.00%)

Education

<Matric n(%)

35

17(37.00%)

18(33.30%)

1.09

.28

Matric n(%)

50

26(57.70%)

24(45.30%)

Above n(%)

05

02(4.30%)

03(4.30%)

Glucose Level

< 250 n(%)

12

08(17.70%)

04(8.80%)

−1.12

.27

> 250–350 n(%)

48

19(42.20%)

29(64.50%)

> 350–500 n(%)

30

18(40.00%)

12(26.70%)

Family System

Nuclear n(%)

57

31(68.90%)

26(57.70%)

1.20

.28

Joint n(%)

33

14(31.20%)

19(42.30%)

Occupation

Unemployed n(%)

48

21(46.70%)

27(60.00%)

1.61

.21

Employee n(%)

42

24(53.40%)

18(40.00%)

SES

Low n(%)

51

24(53.30%)

27(60.10%)

.62

.74

Middle n(%)

29

15(33.30%)

14(31.20%)

High n(%)

10

6(13.30%)

04(8.80%)

Duration. of. Illness

> 2 years n(%)

28

12(26.60%)

16(35.50%)

4.31

.23

3–5 years n(%)

40

18(40.00%)

22(48.90%)

5–10 years n(%)

21

14(31.20%)

07(15.50%)

Type of Treatment

Insulin n(%)

41

22(48.80%)

19(42.30%)

.75

.69

Medication n(%)

42

19(42.30%)

23(51.20%)

Both n(%)

07

04(8.80%)

03(6.60%)

Duration of Treatment

> 6-12 months n(%)

38

19(42.30%)

19(42.30%)

.72

.70

2–3 years n(%)

31

14(31.10%)

17(37.80%)

4–6 years n(%)

21

12(26.60%)

09(20.00%)

Check-up

Daily n(%)

37

19(42.30%)

18(40.10%)

.96

.62

Weekly n(%)

28

16(35.60%)

12(26.70%)

Monthly n(%)

25

14(31.20%)

11(24.50%)

Hypertension

yes n(%)

58

27(60.10%)

31(68.90%)

.78

.38

No n(%)

32

18(40.10%)

14(31.10%)

BMI

Healthy n(%)

26

12(26.60%)

14(31.10%)

.54

.77

Overweight n(%)

25

14(31.10%)

11(24.50%)

Obese n(%)

39

19(42.20%)

20(44.50%)

Family History

Present n(%)

56

26(57.80%)

30(66.70%)

.76

.39

Not Present n(%)

34

19(42.20%)

15(33.40%)

Obesity

Yes n(%)

59

31(68.90%)

28(62.30%)

.45

.51

No n(%)

31

14(31.20%)

17(37.80%)

PHQ

90

16.18(3.85)

15.73(3.83)

.05

.96

SHAI

90

30.11(6.55)

30.02(7.16)

.18

.86

EBS

90

3.70(0.86)

3.77(0.74)

−.37

.72

PDS

90

4.85(0.75)

4.17(0.80)

.89

.22

RDS

90

4.65(0.76)

4.13(0.82)

.75

.35

IDS

90

3.52(1.14)

3.82(0.86)

−.76

.45

DDS

90

16.45(2.73)

15.90(2.76)

.54

.68

PBNA

90

9.11(2.51)

9.49(2.55)

−.08

.99

ADPB

90

7.76(2.14)

7.53(2.19)

− 1.20

.23

CRNA

90

3.98(1.43)

3.76(1.30)

.53

.59

GMAS

90

20.84(4.82)

20.78(5.00)

−.46

.65

SATS

90

67.11(13.53)

70.30(13.74)

−.39

.70

IMPS

90

69.89(12.32)

74.11(12.94)

−1.35

.18

WORS

90

64.89(16.11)

69.19(18.11)

−.80

.42

DQLS

90

67.45(10.58)

71.21(12.12)

−.94

.35

WALS

90

88.24(14.35)

87.80(15.20)

−1.33

.19

MPAS

90

78.00(12.00)

79.00(13.10)

1.03

.31

VPAS

90

65.35(12.36)

64.95(11.93)

−1.02

.32

IPAQ

90

98.26(33.10)

96.56(34.25)

−.93

.36